These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 34707245
21. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses. Quintana VM, Selisko B, Brunetti JE, Eydoux C, Guillemot JC, Canard B, Damonte EB, Julander JG, Castilla V. Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740 [Abstract] [Full Text] [Related]
23. Peptide inhibitors against dengue virus infection. Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829 [Abstract] [Full Text] [Related]
24. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR. Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577 [Abstract] [Full Text] [Related]
25. In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2. Euanorasetr J, Intra B, Thunmrongsiri N, Limthongkul J, Ubol S, Anuegoonpipat A, Kurosu T, Ikuta K, Nihira T, Panbangred W. J Gen Appl Microbiol; 2019 Sep 14; 65(4):197-203. PubMed ID: 30814437 [Abstract] [Full Text] [Related]
26. The Geraniin-Rich Extract from Reunion Island Endemic Medicinal Plant Phyllanthus phillyreifolius Inhibits Zika and Dengue Virus Infection at Non-Toxic Effect Doses in Zebrafish. Haddad JG, Grauzdytė D, Koishi AC, Viranaicken W, Venskutonis PR, Nunes Duarte Dos Santos C, Desprès P, Diotel N, El Kalamouni C. Molecules; 2020 May 15; 25(10):. PubMed ID: 32429073 [Abstract] [Full Text] [Related]
27. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein. Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T. Antiviral Res; 2010 Nov 15; 88(2):236-43. PubMed ID: 20851716 [Abstract] [Full Text] [Related]
28. Baicalein and baicalin as Zika virus inhibitors. Oo A, Teoh BT, Sam SS, Bakar SA, Zandi K. Arch Virol; 2019 Feb 15; 164(2):585-593. PubMed ID: 30392049 [Abstract] [Full Text] [Related]
29. Cardol triene inhibits dengue infectivity by targeting kl loops and preventing envelope fusion. Kanyaboon P, Saelee T, Suroengrit A, Hengphasatporn K, Rungrotmongkol T, Chavasiri W, Boonyasuppayakorn S. Sci Rep; 2018 Nov 09; 8(1):16643. PubMed ID: 30413789 [Abstract] [Full Text] [Related]
30. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes. Hassandarvish P, Oo A, Jokar A, Zukiwski A, Proniuk S, Abu Bakar S, Zandi K. J Antimicrob Chemother; 2017 Sep 01; 72(9):2438-2442. PubMed ID: 28666323 [Abstract] [Full Text] [Related]
31. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses. Yang CC, Hu HS, Lin HM, Wu PS, Wu RH, Tian JN, Wu SH, Tsou LK, Song JS, Chen HW, Chern JH, Chen CT, Yueh A. Antiviral Res; 2019 Dec 01; 172():104636. PubMed ID: 31654671 [Abstract] [Full Text] [Related]
32. The antimicrobial peptide HS-1 inhibits dengue virus infection. Monteiro JMC, Oliveira MD, Dias RS, Nacif-Marçal L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO. Virology; 2018 Jan 15; 514():79-87. PubMed ID: 29153860 [Abstract] [Full Text] [Related]
33. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library. Hernandez-Morales I, Geluykens P, Clynhens M, Strijbos R, Goethals O, Megens S, Verheyen N, Last S, McGowan D, Coesemans E, De Boeck B, Stoops B, Devogelaere B, Pauwels F, Vandyck K, Berke JM, Raboisson P, Simmen K, Lory P, Van Loock M. Antiviral Res; 2017 Nov 15; 147():149-158. PubMed ID: 29037976 [Abstract] [Full Text] [Related]
34. Inhibitory effect of doxycycline against dengue virus replication in vitro. Rothan HA, Mohamed Z, Paydar M, Rahman NA, Yusof R. Arch Virol; 2014 Apr 15; 159(4):711-8. PubMed ID: 24142271 [Abstract] [Full Text] [Related]
35. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice. Abdul Ahmad SA, Palanisamy UD, Khoo JJ, Dhanoa A, Syed Hassan S. Virol J; 2019 Feb 27; 16(1):26. PubMed ID: 30813954 [Abstract] [Full Text] [Related]
36. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide. Chew MF, Tham HW, Rajik M, Sharifah SH. J Appl Microbiol; 2015 Oct 27; 119(4):1170-80. PubMed ID: 26248692 [Abstract] [Full Text] [Related]
37. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly. Anwar A, Hosoya T, Leong KM, Onogi H, Okuno Y, Hiramatsu T, Koyama H, Suzuki M, Hagiwara M, Garcia-Blanco MA. PLoS One; 2011 Oct 27; 6(8):e23246. PubMed ID: 21858043 [Abstract] [Full Text] [Related]
38. Characterization of the mode of action of a potent dengue virus capsid inhibitor. Scaturro P, Trist IM, Paul D, Kumar A, Acosta EG, Byrd CM, Jordan R, Brancale A, Bartenschlager R. J Virol; 2014 Oct 27; 88(19):11540-55. PubMed ID: 25056895 [Abstract] [Full Text] [Related]
39. In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2. Alagarasu K, Patil PS, Shil P, Seervi M, Kakade MB, Tillu H, Salunke A. Peptides; 2017 Jun 27; 92():23-30. PubMed ID: 28400226 [Abstract] [Full Text] [Related]
40. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target. Howe MK, Speer BL, Hughes PF, Loiselle DR, Vasudevan S, Haystead TA. Antiviral Res; 2016 Jun 27; 130():81-92. PubMed ID: 27058774 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]